These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 16721703

  • 1. Pergolide as adjuvant therapy to amisulpride in the treatment of negative and depressive symptoms in schizophrenia.
    Roesch-Ely D, Göhring K, Gruschka P, Kaiser S, Pfüller U, Burlon M, Weisbrod M.
    Pharmacopsychiatry; 2006 May; 39(3):115-6. PubMed ID: 16721703
    [Abstract] [Full Text] [Related]

  • 2. Case report: Effective treatment of Cotard's syndrome: quetiapine in combination with venlafaxine.
    Chan JH, Chen CH, Robson D, Tan HK.
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):125-6. PubMed ID: 19154221
    [No Abstract] [Full Text] [Related]

  • 3. Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.
    Kim SW, Shin IS, Kim JM, Lee SH, Lee JH, Yoon BH, Yang SJ, Hwang MY, Yoon JS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1504-9. PubMed ID: 17692448
    [Abstract] [Full Text] [Related]

  • 4. [Remission of schizophrenic psychosis with negative symptoms with risperidone].
    Lübbe R.
    Fortschr Med; 1996 Feb 28; 114(6):35-6. PubMed ID: 8900527
    [Abstract] [Full Text] [Related]

  • 5. From pharmacological profiles to clinical outcomes.
    Kerwin R.
    Int Clin Psychopharmacol; 2000 Dec 28; 15 Suppl 4():S1-4. PubMed ID: 11252517
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.
    Müller MJ, Regenbogen B, Härtter S, Eich FX, Hiemke C.
    J Psychiatr Res; 2007 Oct 28; 41(8):673-9. PubMed ID: 16324716
    [Abstract] [Full Text] [Related]

  • 7. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
    Cook B, Hoogenboom G.
    Australas Psychiatry; 2004 Mar 28; 12(1):74-6. PubMed ID: 15715745
    [Abstract] [Full Text] [Related]

  • 8. Is amisulpride an 'atypical' atypical antipsychotic agent?
    Lecrubier Y.
    Int Clin Psychopharmacol; 2000 Dec 28; 15 Suppl 4():S21-6. PubMed ID: 11252520
    [Abstract] [Full Text] [Related]

  • 9. Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis.
    Ruhrmann S, Bechdolf A, Kühn KU, Wagner M, Schultze-Lutter F, Janssen B, Maurer K, Häfner H, Gaebel W, Möller HJ, Maier W, Klosterkötter J, LIPS study group.
    Br J Psychiatry Suppl; 2007 Dec 28; 51():s88-95. PubMed ID: 18055944
    [Abstract] [Full Text] [Related]

  • 10. Asymptomatic bradycardia associated with amisulpride.
    Pedrosa Gil F, Grohmann R, Rüther E.
    Pharmacopsychiatry; 2001 Nov 28; 34(6):259-61. PubMed ID: 11778148
    [Abstract] [Full Text] [Related]

  • 11. Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
    Jäger M, Riedel M, Schmauss M, Pfeiffer H, Laux G, Naber D, Gaebel W, Huff W, Schmidt LG, Heuser I, Buchkremer G, Kühn KU, Rüther E, Hoff P, Gastpar M, Bottlender R, Strauss A, Möller HJ.
    Psychiatry Res; 2008 Apr 15; 158(3):297-305. PubMed ID: 18280582
    [Abstract] [Full Text] [Related]

  • 12. Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.
    Croissant B, Hermann D, Olbrich R.
    Pharmacopsychiatry; 2005 Jan 15; 38(1):38-9. PubMed ID: 15706466
    [Abstract] [Full Text] [Related]

  • 13. [Depressive symptoms in active phase of paranoid schizophrenia. Part II: Their link to positive symptoms].
    Grzywa A, Karakuła H.
    Psychiatr Pol; 1998 Jan 15; 32(1):25-36. PubMed ID: 9594581
    [Abstract] [Full Text] [Related]

  • 14. [Treatment resistant schizophrenia, residual subtype: symptom improvement after additional treatment with amisulpride].
    Wolf K, Veismann S, Knecht G, Naber D.
    Psychiatr Prax; 2006 Jan 15; 33(1):42-4. PubMed ID: 16389582
    [Abstract] [Full Text] [Related]

  • 15. [Natural evolution of paranoid schizophrenia treated consecutively with 4 different neuroleptics].
    Portier A, Sarfati Y.
    Encephale; 2000 Jan 15; 26(4):75-7. PubMed ID: 11064844
    [Abstract] [Full Text] [Related]

  • 16. [Electroconvulsive therapy in comorbidity of treatment refractory paranoid hallucinatory psychoses with Parkinson disease].
    Höflich G, Burghof KW, Kasper S, Möller HJ.
    Nervenarzt; 1994 Mar 15; 65(3):202-5. PubMed ID: 7909917
    [Abstract] [Full Text] [Related]

  • 17. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G, Bernardi S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):311-3. PubMed ID: 16919377
    [Abstract] [Full Text] [Related]

  • 18. Cognitive behaviour therapy in patients with schizophrenia who are not prescribed antipsychotic medication: a case series.
    Christodoulides T, Dudley R, Brown S, Turkington D, Beck AT.
    Psychol Psychother; 2008 Jun 30; 81(Pt 2):199-207. PubMed ID: 18230197
    [Abstract] [Full Text] [Related]

  • 19. Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder.
    Müller MJ, Eich FX, Regenbogen B, Sachse J, Härtter S, Hiemke C.
    J Psychopharmacol; 2009 May 30; 23(3):278-86. PubMed ID: 18562411
    [Abstract] [Full Text] [Related]

  • 20. Amisulpride treatment for clozapine-induced sialorrhea.
    Praharaj SK, Sarkar S, Sinha VK.
    J Clin Psychopharmacol; 2009 Apr 30; 29(2):189-90. PubMed ID: 19512987
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.